In conclusion, our data demonstrated the antitumor effect of baicalein in orthotopic NSCLC model for the first time and clarified that Src/Id1 pathway was involved in the baicalein-induced inhibition of tumor growth, providing further insight into the therapeutic strategies. Here, SRC is linked to neoplasm.